227 related articles for article (PubMed ID: 29940145)
1. Improvement of sensitive and specific detection of circulating tumor cells using negative enrichment and immunostaining-FISH.
Li Y; Ma G; Zhao P; Fu R; Gao L; Jiang X; Hu P; Ren T; Wu Y; Wang Z; Cui Z; Yang D
Clin Chim Acta; 2018 Oct; 485():95-102. PubMed ID: 29940145
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
[TBL] [Abstract][Full Text] [Related]
3. Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization.
Ning N; Zhan T; Zhang Y; Chen Q; Feng F; Yang Z; Liu Z; Xu D; Wang F; Guo Y; Xing J; Guan Y; Cui W
Clin Chim Acta; 2014 Jun; 433():69-75. PubMed ID: 24607330
[TBL] [Abstract][Full Text] [Related]
4. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
Tian D; Zhang M; Zheng G; Zhang Y; Li Y; Lin P; Li H; Jiao W; Niu H
Int Urol Nephrol; 2020 Dec; 52(12):2281-2287. PubMed ID: 32748196
[TBL] [Abstract][Full Text] [Related]
6. Effect of circulating tumor cells combined with negative enrichment and CD45-FISH identification in diagnosis, therapy monitoring and prognosis of primary lung cancer.
Chen YY; Xu GB
Med Oncol; 2014 Dec; 31(12):240. PubMed ID: 25361883
[TBL] [Abstract][Full Text] [Related]
7. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Zhang Y; Wang F; Ning N; Chen Q; Yang Z; Guo Y; Xu D; Zhang D; Zhan T; Cui W
Int J Cancer; 2015 Mar; 136(5):1228-33. PubMed ID: 25042121
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer.
Li Y; Tian X; Gao L; Jiang X; Fu R; Zhang T; Ren T; Hu P; Wu Y; Zhao P; Yang D
Cancer Med; 2019 Jul; 8(8):3782-3792. PubMed ID: 31132233
[TBL] [Abstract][Full Text] [Related]
9. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
[TBL] [Abstract][Full Text] [Related]
10. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer.
Yang C; Zhang N; Wang S; Shi D; Zhang C; Liu K; Xiong B
J Transl Med; 2018 May; 16(1):139. PubMed ID: 29792200
[TBL] [Abstract][Full Text] [Related]
11. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
12. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
[No Abstract] [Full Text] [Related]
13. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
[TBL] [Abstract][Full Text] [Related]
14. Method for semi-automated microscopy of filtration-enriched circulating tumor cells.
Pailler E; Oulhen M; Billiot F; Galland A; Auger N; Faugeroux V; Laplace-Builhé C; Besse B; Loriot Y; Ngo-Camus M; Hemanda M; Lindsay CR; Soria JC; Vielh P; Farace F
BMC Cancer; 2016 Jul; 16():477. PubMed ID: 27417942
[TBL] [Abstract][Full Text] [Related]
15. Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer.
Tan CL; Lim TH; Lim TKh; Tan DS; Chua YW; Ang MK; Pang B; Lim CT; Takano A; Lim AS; Leong MC; Lim WT
Oncotarget; 2016 Apr; 7(17):23251-62. PubMed ID: 26993609
[TBL] [Abstract][Full Text] [Related]
16. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
Ge F; Zhang H; Wang DD; Li L; Lin PP
Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization.
Liu X; Zhang Z; Zhang B; Zheng Y; Zheng C; Liu B; Zheng S; Dong K; Dong R
EBioMedicine; 2018 Sep; 35():244-250. PubMed ID: 30104180
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of circulating tumor cells in patients with ampullary cancer.
Sun B; Liu H; Wang S; Xiang J; Liu X
J Cell Physiol; 2018 Jun; 233(6):5014-5022. PubMed ID: 29215725
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W
Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.
Pailler E; Adam J; Barthélémy A; Oulhen M; Auger N; Valent A; Borget I; Planchard D; Taylor M; André F; Soria JC; Vielh P; Besse B; Farace F
J Clin Oncol; 2013 Jun; 31(18):2273-81. PubMed ID: 23669222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]